SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $26,000 | -33.3% | 110,400 | 0.0% | 0.00% | – |
| Q4 2015 | $39,000 | -79.7% | 110,400 | 0.0% | 0.00% | – |
| Q3 2015 | $192,000 | -6.3% | 110,400 | +20.1% | 0.00% | -100.0% |
| Q2 2015 | $205,000 | +15.2% | 91,900 | 0.0% | 0.00% | – |
| Q1 2015 | $178,000 | -6.8% | 91,900 | +27.8% | 0.00% | -100.0% |
| Q4 2014 | $191,000 | -3.5% | 71,900 | +9.4% | 0.00% | 0.0% |
| Q3 2014 | $198,000 | -26.4% | 65,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $269,000 | -4.9% | 65,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $283,000 | 0.0% | 65,700 | +21.7% | 0.00% | 0.0% |
| Q4 2013 | $283,000 | -0.7% | 54,000 | +19.5% | 0.00% | 0.0% |
| Q3 2013 | $285,000 | +26.1% | 45,200 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $226,000 | – | 45,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,696,894 | $7,637,000 | 32.03% |
| Anson Funds Management LP | 989,204 | $348,000 | 0.11% |
| CAXTON CORP | 62,000 | $22,000 | 0.09% |
| McQueen, Ball & Associates Inc. | 102,742 | $36,000 | 0.03% |
| Sheaff Brock Investment Advisors, LLC | 320,000 | $113,000 | 0.01% |
| Roundview Capital LLC | 21,100 | $7,000 | 0.00% |
| QCM Cayman, Ltd. | 11,197 | $4,000 | 0.00% |
| ZACKS INVESTMENT MANAGEMENT | 193,406 | $68,000 | 0.00% |
| Renaissance Technologies | 2,504,200 | $881,000 | 0.00% |
| Squarepoint Ops LLC | 56,800 | $20,000 | 0.00% |